Trial Profile
Immunological Effects of an Acellular Pertussis Booster Vaccination in Children, Young Adults and Elderly With Different Immunisation Background. An International Study in Finland, the Netherlands and the United Kingdom
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 25 Aug 2021
Price :
$35
*
At a glance
- Drugs DTaP poliovirus vaccine (Primary)
- Indications Pertussis
- Focus Pharmacodynamics
- Acronyms BERT
- 07 Jan 2021 Status changed from active, no longer recruiting to completed.
- 12 Dec 2020 This trial is completed in UK (Global End Date: 14 Jan 2020), according to European Clinical Trials Database record.
- 13 Apr 2020 As per European Clinical Trials Database trial has been completed in Finland.